The relationship of individual comorbid chronic conditions to diabetes care quality.

OBJECTIVE: Multimorbidity affects 26 million persons with diabetes, and care for comorbid chronic conditions may impact diabetes care quality. The aim of this study was to determine which chronic conditions were related to lack of achievement or achievement of diabetes care quality goals to determine potential targets for future interventions. RESEARCH DESIGN AND METHODS: This is an exploratory retrospective analysis of electronic health record data for 23 430 adults, aged 18-75, with diabetes who were seen at seven Midwestern US health systems. The main outcome measures were achievement of six diabetes quality metrics in the reporting year, 2011 (glycated haemoglobin (HbA1c) control and testing, low-density lipoprotein control and testing, blood pressure control, kidney testing). Explanatory variables were 62 chronic condition indicators. Analyses were adjusted for baseline patient sociodemographic and healthcare utilization factors.
RESULTS: The 62 chronic conditions varied in their relationships to diabetes care goal achievement for specific care goals. Congestive heart failure was related to lack of achievement of cholesterol management goals. Obesity was related to lack of HbA1c and BP control. Mental health conditions were related to both lack of achievement and achievement of different care goals. Three conditions were related to lack of cholesterol testing, including congestive heart failure and substance-use disorders. Of 17 conditions related to achieving control goals, 16 were related to achieving HbA1c control. One-half of the comorbid conditions did not predict diabetes care quality.
CONCLUSIONS: Future interventions could target patients at risk for not achieving diabetes care for specific care goals based on their individual comorbidities.

Individual conditions have unique relationships with diabetes care goal achievement.

Congestive heart failure was associated with lack of achievement of both low-density lipoprotein control and testing goals.

Individual mental health conditions were associated with not achieving certain care goals, and achieving other care goals.

The vast majority, over 83%, of patients with diabetes in the USA, has at least one other co-occurring chronic condition, and diabetes care quality remains suboptimal with staggering levels of morbidity and mortality.1 2 Multimorbidity adds additional care demands to the already complex diabetes care. The US Department of Health and Human Services, The Institute of Medicine, the Patient-Centered Outcome Research Institute and others have recognized the need to understand and improve multimorbidity care.3–6 Unfortunately, there are few current multimorbidity interventions to improve diabetes care, as demonstrated by a recent Cochrane review.7 One reason for the limited number of interventions may be that the relationship of individual comorbid chronic conditions to elements of diabetes care is not known.3 Only a few specific conditions, such as hypertension and depression,8–10 have been assessed for their individual impact on diabetes care and even then for a limited set of care goals. As diabetes care quality consists of achieving multiple care goals, including both testing and control goals, individual conditions could have a different relationship with diabetes care for each care goal. Without knowing these relationships, we cannot identify patients at risk for not achieving care goals based on their comorbidities, and we cannot target interventions to improve care for specific diabetes care goals in patients with the selected comorbidities.

Do these relationships hold up in other populations?

How do individual conditions and combinations of individual conditions relate to other outcomes in patients with diabetes?

How can we best improve care for patients with diabetes and select comorbid conditions?

A conceptual model suggests that the relationship between comorbid conditions and diabetes care is due to characteristics of the comorbid condition.11 In this framework, patients with conditions that share care goals with diabetes (concordant) are more likely to achieve diabetes care goals, while patients with conditions that do not share care (discordant) are less likely to achieve diabetes care goals. In addition, care for severe and/or symptomatic conditions would preferentially be prioritized over care for diabetes. Past studies on the impact of chronic conditions on diabetes management have considered only one condition characteristic (eg, concordant/discordant or severe/not severe) and considered all conditions classified as the same type (eg, discordant) as equivalent when determining impact on diabetes care.11–16 However, in actuality, some conditions might have a greater or lesser impact on diabetes testing and control goal achievement than other conditions. For example, a diagnosis of cancer might have a greater impact on diabetes management than heartburn. It is most likely that the overall impact of a chronic condition on diabetes care is due to a combination of its many characteristics (concordant/discordant, severity, symptom level) as well as other factors such as treatment needs and pathophysiology. Therefore, it is important to consider the impact of individual conditions, not just classes of conditions based on their characteristics.

The objective of this study was to determine the relationship between individual chronic conditions and the achievement of publicly-reported diabetes quality care goals in patients with diabetes. We did this at the individual condition level to study the combined impact of all potential condition characteristics. We hypothesized that the relationship between the condition and the achievement of diabetes care goals would vary for each condition and care goal, with achievement of that goal (positive association with achievement), lack of achievement of that goal (negative association with achievement), or no relationship with care (no association).

Research design and methods

Design and setting

We conducted a retrospective analysis of 2 years of electronic health data, 2010 (baseline year) and 2011 (quality reporting year), for seven health systems that participated in a Midwestern quality reporting collaborative, the Wisconsin Collaborative for Healthcare Quality. The health systems are academic and community practices in rural, suburban and urban settings, and all submit data electronically for public reporting using standardized methodology.17 The Minimal Risk Health Sciences Institutional Review Board at the University of Wisconsin determined that the project was exempt from oversight.

Patients

All patients with a diagnosis of diabetes (type 1 or type 2), who were 18–75 years old, and were medically homed within the seven participating health systems were included in the sample.17 We focused on patients eligible for public reporting of diabetes quality care metrics to ensure general consensus about the definition of diabetes quality care goals. Diabetes was defined by at least two face-to-face ambulatory visits (using CPT-4 outpatient evaluation and management codes) with any clinician with an International Classification of Diseases Ninth Edition (ICD-9) diagnosis code of 250.XX, 357.2, 362.0X, 366.41 or 648.0X on different dates of service over the 2 years of data.17 Medically homed was defined as at least two face-to-face office visits to the group on different dates of service in the past 2 years, with at least one visit in the reporting year.17

Primary outcome variables

Our primary outcome variables were the achievement of three control and three testing diabetes care goals, recommended in clinical guidelines, used in public reporting, measurable in a standardized fashion across populations and health systems and shown to be associated with macrovascular and microvascular outcomes in diabetes.17 18 Variables were binary, representing care goal achievement or not in the reporting year, as defined by the public reporting collaborative that reports on the participating health systems. The three control goals were: HbA1c control <7% (or <8% if 65–75 years old or having specific comorbidities);17–19 LDL cholesterol control <100 mg/dL; blood pressure (BP) control at <130/80 mm Hg. The specific comorbidities were: coronary artery bypass graft, percutaneous transluminal coronary angioplasty, ischemic vascular disease, congestive heart failure, myocardial infarction, chronic renal failure, dementia, blindness and amputation (lower extremity).17

The three testing goals measured in the reporting year were as follows: HbA1c testing two or more times; LDL cholesterol testing; kidney function testing by either a urine microalbumin test or documented evidence of nephropathy.17 18 Documented evidence of nephropathy, as defined by the public reporting collaborative that reports on the participating health systems, included a visit to a nephrologist for any reason, a diagnosis code for chronic kidney disease or renal manifestations of diabetes or evidence of dialysis treatment during the reporting year.17

Main explanatory variables

Indicator variables for patient comorbidities were the main explanatory variables. We used a comprehensive set of 62 chronic condition indicators (excluding diabetes) based on an established list of outpatient-relevant chronic conditions developed from the AHRQ Clinical Classification Software (CCS) categories for medical conditions.20 21 The 62 chronic condition indicators cover 1412 ICD-9 codes, with several codes for similar or the same condition(s) counted as the presence of one condition (eg, multiple codes for types of coronary artery disease are counted as the patient having a coronary artery disease). Chronic conditions were defined as ICD-9 codes billed at one or more face-to-face visits in the baseline year. This was carried out to ensure that the conditions were present and actively managed in the clinic before the quality reporting time frame. See online supplementary appendix table 1 for a list of the 62 conditions organized by body system.

Covariates

We defined variables for patient sociodemographic characteristics and healthcare utilization. Sociodemographic characteristics were age (continuous), gender, race (white or other) and insurance (non-commercial Medicare, Medicaid, commercial (including commercial Medicare) or self-pay/unreported). We defined two additional socioeconomic status proxy variables by linking patient zip codes to census tract data. These are the per cent of the population in the patient's zip code who live below the poverty line and the per cent who do not have a high school education. Healthcare utilization was defined as number of face-to-face office visits in the baseline year (coded as 4 categories).17 22 We also included an indicator for health system to account for clustering. To account for potential contextual effects, we developed a variable for the prevalence of self-reported diabetes in each patient's county of residence, and a variable for the per cent of all Medicare patients in the county who have had HbA1c testing, from patient zip codes linked to the University of Wisconsin Population Health Institute-Robert Wood Johnson County Health Rankings.23 We also determined rural–urban commuting area codes based on each patient's zip code (RUCA, 4 level).24

Statistical analyses

All analyses were conducted using Stata V.13.0 (Stata-Corp, College Station, Texas, USA). There were no missing data for any covariates or outcome variables. Outcome variables were coded as testing or control thresholds being met when in the health record, and not being met when not recorded, as is the standard for public reporting. Descriptive analyses summarized categorical variables using percentages and continuous variables using means with SDs. Logistic regression models were fit for each of the six diabetes control and testing goals, to assess the relationship between 58 individual chronic conditions and the achievement of each care goal, adjusted for covariates as described above. All conditions with more than 20 patients and all covariates were used in all models to include all potentially relevant variables. Four conditions with fewer than 20 conditions (<0.1% prevalence) were not included in the model: cystic fibrosis, tuberculosis, sickle cell anemia and amyloidosis. Results are reported as OR and 95% CIs. The significance of each condition on diabetes goal achievement was determined at p value<0.01. These conservative significance values were used for this exploratory study to account for multiple comparisons, while avoiding unnecessary increases in type 2 error that can occur with Bonferroni correction. All conditions with significant associations (p value<0.01) were present in at least 93 patients.

Results

Patient characteristics

Our sample had 23 430 patients with diabetes, between the ages of 18 and 75 (table 1). Patients had 0–22 comorbid conditions, with an average of 3.8 (SD=2.5) and a median of 3. The frequencies of all 62 chronic conditions ranged from 77% for hyperlipidemia to 0.01% for tuberculosis (see online supplementary appendix table 1).

Table 1

Patient characteristics for total sample of patients with diabetes aged 18–76

	Total sample (n=23 430)
Comorbidities
None (diabetes only, no other chronic conditions), %	7.7
Number of total comorbid conditions, mean (SD)	3.8 (2.5)
Number of concordant comorbid conditions, mean (SD)	2.2 (1.3)
Number of discordant comorbid conditions, mean (SD)	1.7 (1.7)
Age, mean (SD)	57.6 (1.7)
Sex, female, %	48
Race/ethnicity, white, %	70
Insurance, %
Commercial	50
Medicare	33
Medicaid	6
Uninsured/unreported, %	12
Number of visits in baseline year
<2	27
3 to 10	58
11 to 29	15
30 or more	1
RUCA, by patient’s zip code, %
Urban core	52
Suburban	16
Large own	9
Small town and rural	23
Per cent with diabetes in patient’s county, mean (SD)	8 (1)
Per cent with diabetes in patient’s county who achieved HbA1c testing, mean (SD)	89 (2.9)
Per cent below poverty line in patient’s zip code, mean (SD)	12 (8.7)
Per cent without HS education in patient’s zip code, mean (SD)	10 (5.6)

%, percentage; HbA1c, glycated haemoglobin.

Relationship of individual chronic conditions to diabetes control

After controlling for patient sociodemographic factors and number of office visits, nine conditions predicted lack of achievement of specific control goals (table 2). Of these conditions, five were related to not achieving HbA1c control, including obesity and depression. Eight conditions were related to lack of achievement of cardiovascular risk reduction goals (LDL and/or BP control). These included: congestive heart failure (CHF), hypertension, obesity, anxiety and substance abuse.

Table 2

Impact of individual concordant and discordant conditions on diabetes control goal achievement, adjusted, OR (95% CI), with prevalence of conditions, among patients with diabetes age 18–75

	Prevalence % (n=23 430)	HgbA1c control		LDL control		BP control
		OR (95% CI)	p Value	OR (95% CI)	p Value	OR (95% CI)	p Value
Lack of control goal achievement
Obesity	22	0.9 (0.8 to 0.97)	0.0060			0.9 (0.85 to 0.97)	0.0050
Depression	15	0.9 (0.8 to 0.9)	0.0010
Anxiety disorders	8.0			0.8 (0.8 to 0.9)	0.0010
CNS/PNS disorders*	7.8	0.8 (0.7 to 0.9)	0.0000
Congestive heart failure	5.0			0.8 (0.7 to 0.9)	0.0060
Skin ulcer	4.8	0.8 (0.7 to 0.9)	0.0010
Degenerative eye problem	4.3	0.7 (0.6 to 0.8)	0.0000
Substance use disorders	0.8					0.6 (0.43 to 0.8)	0.0010
Mixed lack of achievement and achievement
Hypertension	74	1.1 (1.04 to 1.2)	0.0030	1.2 (1.1 to 1.3)	0.0000	0.6 (0.55 to 0.6)	0.0000
Control goal achievement
Hyperlipidemia	77	1.1 (1.1 to 1.2)	0.0000	1.3 (1.2 to 1.3)	0.0000	1.3 (1.17 to 1.3)	0.0000
Osteoarthritis	16	1.2 (1.1 to 1.3)	0.0000
Coronary atherosclerosis	14	1.3 (1.2 to 1.4)	0.0000	1.5 (1.4 to 1.6)	0.0000	1.3 (1.21 to 1.4)	0.0000
Allergic rhinitis	11	1.2 (1.1 to 1.3)	0.0000
Cancer	7.6	1.3 (1.1 to 1.4)	0.0000
Cardiac dysrhythmia	7.3					1.2 (1.05 to 1.3)	0.0040
Kidney and vesicoureteral disorders†	4.8			1.2 (1.05 to 1.4)	0.0090
Gout or other crystal arthropathy	4.4	1.2 (1.1 to 1.4)	0.0050
Benign prostatic hypertrophy	4.1	1.3 (1.1 to 1.6)	0.0010	1.2 (1.05 to 1.4)	0.0090
Bipolar disorder	3.7	1.2 (1.1 to 1.4)	0.0090
Rheumatoid arthritis	1.5	1.6 (1.3 to 2.1)	0.0000
Schizophrenia and psychotic disorders	1.1	1.7 (1.2 to 2.2)	0.0010
Aneurysm	0.7	1.9 (1.2 to 3)	0.0060
Epilepsy	0.7	2.1 (1.4 to 3.1)	0.0000
Myocardial infarction§	0.5	2.0 (1.2 to 3.2)	0.0080
Parkinson’s disease	0.4	2.8 (1.4 to 5.4)	0.0020			2.4 (1.47 to 3.9)	0.0000

Adjusted for age, sex, race, insurance, number of face-to-face office visits in the baseline year, patient rural–urban commuting area, per cent with diabetes in patient’s county, per cent of Medicare patients with diabetes in patient’s county who achieved HbA1c testing, per cent below poverty line in patient’s zip code, per cent without high school education in patient’s zip code, health system.

All 62 conditions were included in the model. Only conditions with significant associations at p value<0.01 are listed in the table. All conditions are mutually exclusive.

*Excludes malignancies, multiple sclerosis and epilepsy.

†Excludes kidney failure.

§Within past 2 years.

CNS/PNS, central nervous system and peripheral nervous system; HbA1c, glycated haemoglobin.

Seventeen conditions were related to achieving control goals, and 15 to HbA1c control. Among these were schizophrenia and bipolar disorder. Blood pressure control was achieved with four conditions, including obesity and substance use disorders.

Relationship of individual chronic conditions to diabetes testing

All conditions that were related to lack of achievement of testing goals were related to LDL testing (table 3).These included: CHF and substance use disorders.

Table 3

Impact of individual concordant and discordant conditions on diabetes testing goal achievement, adjusted, OR (95% CI), with prevalence of conditions, among patients with diabetes age 18–75

		Diabetes care goal achieved
	Prevalence % (n=23 430)	HbA1c testing		LDL testing		Kidney testing
		OR (95% CI)	p Value	OR (95% CI)	p Value	OR (95% CI)	p Value
Lack of testing goal achievement
Congestive heart failure	5.0			0.6 (0.5 to 0.8)	0.0000
Substance use disorders	0.8			0.6 (0.4 to 0.8)	0.0010
Anemia	0.4			0.4 (0.2 to 0.7)	0.0020
Testing goal achievement
Hyperlipidemia	77	1.4 (1.3 to 1.5)	0.0000	2.9 (2.7 to 3.2)	0.0000	1.4 (1.3 to 1.5)	0.0000
Hypertension	74	1.1 (1.03 to 1.2)	0.0060
Obesity	22	1.2 (1.1 to 1.3)	0.0000
Thyroid disorder	15	1.2 (1.1 to 1.3)	0.0010
Coronary atherosclerosis	14			1.3 (1.1 to 1.5)	0.0010
Renal failure	11	1.3 (1.2 to 1.5)	0.0000			29.1 (18.6 to 45.4)	0.0000
CNS/PNS disorders*	7.8	1.2 (1.1 to 1.4)	0.0060
Kidney and vesicoureteral disorders†	4.8					2 (1.5 to 2.7)	0.0000
Menopause and perimenopause	3.6			1.5 (1.1 to 1.9)	0.0030

Bold represents conditions associated with lack of goal achievement.

Adjusted for age, sex, race, insurance, number of face-to-face office visits in the baseline year, patient rural–urban commuting area, per cent with diabetes in patient’s county, per cent of Medicare patients with diabetes in patient’s county who achieved HbA1c testing, per cent below poverty line in patient’s zip code, per cent without high school education in patient’s zip code, health system.

All 62 conditions were included in the model. Only conditions with significant associations at p value<0.01 are listed in the table. All conditions are mutually exclusive.

*Excludes malignancies, multiple sclerosis and epilepsy.

‡Excludes kidney failure.

CNS/PNS, central nervous system and peripheral nervous system; HbA1c, glycated haemoglobin.

Obesity was among six conditions related to achieving the HbA1c testing goal. Renal failure was strongly associated with achieving kidney testing with an OR of 29.1 (95% CI 18.6 to 45.4); a diagnosis of renal failure meets the kidney testing metric by definition.

Conditions with no relationship to diabetes control or testing

Of 62 conditions, 33 were related to neither control nor testing care goal achievement at p value <0.01, 4 additional conditions were not related to control but were related to testing, and 17 were not related to testing but were related to control (table 4). These conditions span multiple organ systems including cardiovascular and mental health conditions, and many are low prevalence.

Table 4

Individual chronic conditions with no significant effect on diabetes control or testing goal achievement

Both control and testing goal achievement	Control goal achievement only	Testing goal achievement only
Cardiac, vascular and pulmonary	Genitourinary and reproductive	Cardiac, vascular and pulmonary
COPD or asthma	Renal failure	Cardiac dysrhythmia
Stroke and TIA	Menopause/perimenopause	Aneurysm
Peripheral atherosclerosis		Myocardial infarction
Vascular disease*	Allergy and immunity
Cardiomyopathy	Immunity disorder	Muscoskeletal
Heart valve disorder	Endocrine	Osteoarthritis
Pulmonary heart disease	Thyroid disorder	Gout
Congenital heart disease		Mental health
Thrombosis and embolism		Depression
Muscoskeletal		Anxiety disorders
Back problem		Bipolar disorder
Mental health		Schizophrenia
Behavior disorders		Genitourinary and reproductive
Personality disorder		Benign prostatic hypertrophy
Sleep disorders		Allergy and immunity
Gastrointestinal		Allergic rhinitis
Pancreatitis		Rheumatoid arthritis
Intestinal disorders		Hematological and oncological
Liver disease†		cancer
Esophageal disorder		Neurological
Hepatitis		Epilepsy
Genitourinary and reproductive		Parkinson’s disease
Female genitourinary disorders		Other
Polycystic ovarian syndrome		Degenerative eye disorder
Allergy and immunity		Skin ulcer
HIV
Lupus
Tuberculosis
Hematological and oncological
Anemia
Sickle cell anemia
Neurological
Migraines
Dementia
Paralysis
Multiple sclerosis
Other
Non-cardiac congenital disorder
Sarcoidosis
Amyloidosis
Cystic fibrosis

*Non-thrombotic, non-athlerosclerotic.

‡Excluding chronic hepatitis.

COPD, chronic obstructive pulmonary disease.

Discussion

We found that, as expected, the 62 chronic conditions varied in their relationships to diabetes care goal achievement for specific care goals. Several of the results are especially pertinent to diabetes care and the development of future interventions for care in multimorbidity. CHF, obesity, and mental health disorders were all related to lack of achievement for specific goals. HbA1c control was achieved across multiple conditions, and for many more conditions than LDL or BP control. Lack of achievement of a testing goal was only seen with LDL testing, with three individual conditions. Finally, half of the comorbid conditions had no relationship to any of the six diabetes care goals. Future interventions can target selectively patients with specific comorbidities that are associated with lack of achievement of diabetes care goals.

CHF was related to lack of achievement of both LDL control and testing. This was surprising as LDL management is integral in CHF care, and based on the conceptual model of shared care leading to better diabetes care, we expected CHF to be associated with achieving LDL management goals.11 25 CHF showed no significant association with BP control or HbA1c testing or control. The reason that patients with CHF appear less likely to achieve LDL control, but not less likely to achieve BP control, an important goal in CHF,25 or HbA1c control, could be due in part to patient priorities as a past study that showed that cholesterol control was a lower priority than BP or HbA1c control to patients with diabetes.26

Obesity was related to lack of achievement of HbA1c and BP control, but achievement of the HbA1c testing goals. The lack of control could be due to glucose and BP dysregulation in obesity, or lifestyle factors that worsen weight, HbA1c, and BP control. The lack of HbA1c control despite guideline-adequate testing highlights the relative difficulty of achieving control compared to completing a non-fasting laboratory test. Control requires counseling at a visit and between-visit self-care for a guideline-recommended 2 h/day,27 while ordering a laboratory test and completing it at the visit, requires relatively minimal effort from the provider and patient.

Interestingly, while three mental health conditions were associated with not achieving diabetes care for specific care goals, this was not for the same goals, and not all mental health conditions were related to lack of care goal achievement. Mental health conditions can present barriers to diabetes care through lack of motivation or an ability to perform self-care.8 28 Patients who do not take prescribed medications or follow lifestyle recommendations are less likely to achieve diabetes care goals. Although we found associations with lack of care goals achievement for patients with depression, substance abuse and anxiety, we also found care goals achievement with schizophrenia and bipolar disorder. Previous studies on major mental health disorders in diabetes showed better HbA1c control among those with schizophrenia than those without major mental health conditions.29 This could be due to increased provider attention on these perceived high-risk patients. Our results suggest that mental health barriers to diabetes care vary by both condition and care goal, and are more complicated than a simple negative association with any care for all mental health conditions.

Notably, the vast majority of conditions that were related to achieving at least one control goal were related to achieving HbA1c control (15 of 17), while only seven conditions were related to achieving cardiovascular control goals (LDL and BP). This is a matter of concern as evidence shows that cardiovascular risk reduction is more likely to reduce mortality in diabetes than glycemic control.30 31 Several of the conditions that were related to achieving HbA1c control, but not cardiovascular risk reduction, are not traditionally considered diabetes-related (eg, allergic rhinitis, cancer) and should be less likely to support HbA1c control.11 These results may be at least partially explained by HbA1c control being prioritized over other care in diabetes, especially by patients,26 as glycemic control has long been the major focus on diabetes care.

All conditions that were related to any lack of achievement of testing goals were related to not achieving the LDL testing goal. One possible explanation for the lack of LDL testing with many of these conditions is the potential lack of provider cuing to order the test when LDL testing is not a shared care goal between diabetes and the comorbidity.11 We have seen in prior work that patients with diabetes and conditions that share cardiovascular care, such as hyperlipidemia, are more likely to have LDL testing performed than patients who do not have conditions that share diabetes care.12 Another possible explanation is that the LDL test is more challenging for patients to complete, compared to the HbA1c or kidney test, as it requires fasting and often a return visit. There were no conditions associated with not achieving HbA1c or kidney testing, both tests that can be performed without fasting. Past work showed patients prioritize diabetes care less than other healthcare when they had non-diabetes-related competing health problems.13 It could be that patients do not prioritize an inconvenient test when they have other competing demands that do not share the LDL testing goal.11–13

Over half of the conditions studied had no relationship to any testing or control goals. Among these conditions are many that share diabetes care goals (eg, peripheral atherosclerosis) and could be expected to support goal achievement.11 Many were conditions that can be symptomatic (eg, back problems) or severe (eg, stroke), and therefore could distract from diabetes care.11 This finding suggests that overlap of goals with diabetes care, or potential for symptoms, is alone insufficient to determine if a comorbid condition will be related to achievement or lack of achievement of diabetes care goals. Other factors, such as preference for care, patient context, and health system characteristics, play a role and must be considered in multimorbidity care.5 32

Strengths and limitations

The major strengths of this study are the inclusion of a comprehensive set of 62 chronic conditions, six diabetes care goals, and a large sample across multiple health systems. It is important to acknowledge that the sample is from one Midwest state and only includes health systems that participate in public reporting and that this may limit generalizability. However, patients come from a wide range of ages, race/ethnicities and payors, we were able to adjust for multiple patient characteristics, the health systems did not all share any common care approaches or characteristics, and diabetes care goal achievement was similar to results from a national sample in 2011.33 While we included several sociodemographic variables, we recognize that in our study, as in any similar analysis, there were unmeasured patient characteristics for which we could not make adjustments. To establish actively managed comorbid conditions, we used ICD-9 codes billed at face-to-face visits in the baseline year, as has been performed previously.20 21 There is a risk for underdiagnosis of certain conditions with this approach, such as obesity34 and depression;35 however, there is less risk of bias than with condition patient self-report.21 There is also a potential for patients to receive some care and achieve diabetes care goals outside of their medical home health system, and this goal achievement would not be recognized in our analysis. Our statistical approach included multiple variables, and many conditions were of low prevalence. We chose not to correct for multiple comparisons, such as with the Bonferroni method, to avoid increasing type 2 error in this first-step study. Instead, we used a p value <0.01 to determine significant associations. We do note that the impact of some conditions on care goal achievement are small in magnitude while statistically significant (ie, OR 1.1) and their clinical significance therefore could be limited and should be tested in other populations in future work. There is also a potential for interaction effects among conditions, but these were not studied in the current analyses and the impact of combinations of conditions should be studied in future work. Finally, we used publicly reported testing and control care goals as markers of diabetes quality, as these are relevant to our population of patients with diabetes, consistently measurable, and there is agreement that achieving these goals leads to better long-term outcomes.7 31 It is important to note that there are other aspects of care, other health outcomes and patient factors that were not tested in this study as the study was not designed to address them, including patient preference for care, patient contextual factors and provider and health system priorities for care.5 11 13 32 We also recognize that some of our findings could be due to chance. Future work should assess broader, more patient-oriented long-term outcomes, such as health-related quality of life and mortality and include more patient sociodemographic and context measures.

Implications

Our findings on the relationship between individual chronic conditions and diabetes care goal achievement have several implications for the design of future multimorbidity interventions if borne out in future research. It is well established that there is a potential to improve control through better self-care and better testing. The importance of BP and LDL control alongside HbA1c control could be emphasized in patient education. Our results support targeted lifestyle interventions for patients with diabetes and co-occurring conditions that are associated with lack of care goal achievement of more than one goal, such as CHF or obesity. Patient-centered medical home elements, such as registries and group visits,36 could target patients with diabetes and specific comorbidities to provide supportive, integrated diabetes and comorbidity care.26 37 This may also help patients and providers prioritize diabetes care goals, such as when achieving a care goal can benefit multiple conditions32 and to maximize benefits while decreasing harms, especially among patients in whom it might not be appropriate to achieve all diabetes care goals.7 38 Additional previsit planning to ensure fasting laboratory completion,36 or non-fasting lipid tests could be used to increase cholesterol testing.39 Finally, given that over half of the tested conditions had no relationship with diabetes care, these conditions could be de-emphasized in certain situations in order to create a more manageable list of conditions for which care could be integrated.40

Diabetes rarely occurs outside the setting of multimorbidity, multimorbidity complicates diabetes care and interventions are urgently needed to effectively manage these complex patients. Our study shows which conditions are associated with achieving specific diabetes care goals. If these results are borne out in further studies in different populations, future interventions could target patients at risk for not achieving specific diabetes care goals based on their individual comorbidities.